New Oxygenator Improves Cardiopulmonary Bypass Care
|
By HospiMedica International staff writers Posted on 29 Jan 2019 |

Image: The new Capiox NX19 Oxygenator with UltraPrime Technology (Photo courtesy of Terumo).
A novel oxygenator helps minimize the impact of cardiopulmonary bypass by reducing hemodilution, minimizing inflammatory response, and providing highly efficient gaseous microemboli (GME) removal.
The Terumo Cardiovascular Group (Ann Arbor, MI, USA) Capiox NX19 Oxygenator with UltraPrime Technology is intended for the exchange of gases between bloodcells and a gaseous environment, in order to satisfy the oxygenation needs of adult patients during cardiopulmonary bypass surgery. An integrated arterial filter removes non-biologic particles and emboli and facilitates air bubble removal from the blood flowing through the cardiopulmonary bypass circuit. In addition, an integrated heat exchanger is used to warm or cool blood and/or perfusion fluid as it flows through the device.
A hardshell reservoir stores blood during extra-corporeal circulation, with a venous section comprised of a filter and defoamer to facilitate air bubble removal, and a cardiotomy section that contains a filter to remove particulate matter, as well as an additional defoamer. The technology is based on proprietary hollow fibers woven in a unique pattern, providing a low priming volume of just 185 mL, thus delivering high gas exchange performance without increasing pressure drop. The low priming volume also reduces hemodilution, leading to fewer blood transfusions and lower risk of acute kidney injury (AKI).
“The Capiox NX19 oxygenator is the next step in Terumo's legacy of oxygenator innovation,” said Robert De Ryke, President and CEO of Terumo Cardiovascular Group. “Terumo introduced the world's first hollow fiber oxygenator in 1982 and remains at the forefront of the industry, developing high quality products that help save patient lives.”
Cardiopulmonary bypass is a is a form of extracorporeal circulation that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body. The cardiopulmonary bypass pump, often referred to as a heart–lung machine, is operated by perfusionists.
Related Links:
Terumo Cardiovascular Group
The Terumo Cardiovascular Group (Ann Arbor, MI, USA) Capiox NX19 Oxygenator with UltraPrime Technology is intended for the exchange of gases between bloodcells and a gaseous environment, in order to satisfy the oxygenation needs of adult patients during cardiopulmonary bypass surgery. An integrated arterial filter removes non-biologic particles and emboli and facilitates air bubble removal from the blood flowing through the cardiopulmonary bypass circuit. In addition, an integrated heat exchanger is used to warm or cool blood and/or perfusion fluid as it flows through the device.
A hardshell reservoir stores blood during extra-corporeal circulation, with a venous section comprised of a filter and defoamer to facilitate air bubble removal, and a cardiotomy section that contains a filter to remove particulate matter, as well as an additional defoamer. The technology is based on proprietary hollow fibers woven in a unique pattern, providing a low priming volume of just 185 mL, thus delivering high gas exchange performance without increasing pressure drop. The low priming volume also reduces hemodilution, leading to fewer blood transfusions and lower risk of acute kidney injury (AKI).
“The Capiox NX19 oxygenator is the next step in Terumo's legacy of oxygenator innovation,” said Robert De Ryke, President and CEO of Terumo Cardiovascular Group. “Terumo introduced the world's first hollow fiber oxygenator in 1982 and remains at the forefront of the industry, developing high quality products that help save patient lives.”
Cardiopulmonary bypass is a is a form of extracorporeal circulation that temporarily takes over the function of the heart and lungs during surgery, maintaining the circulation of blood and the oxygen content of the body. The cardiopulmonary bypass pump, often referred to as a heart–lung machine, is operated by perfusionists.
Related Links:
Terumo Cardiovascular Group
Latest Surgical Techniques News
- Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
- Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read more
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







